On the other hand, RDs and RDNs may be more likely to become involved in these cases through medical settings, since these are prescription medications
Self-controlled analysis showed the highest risk of alcohol-related events in the 3-month pretreatment period, whereas the risk was lowest in the first 3-month treatment period
Your journey to personalized care starts here
Providers typically evaluate BMI status, presence of obesity-related complications, documented metabolic dysfunction, cardiovascular risk, previous weight-loss interventions, and family history of metabolic disease
But the study is on par with what we see clinically in many people who stop GLP-1 medications, says Chika Anekwe, an obesity medicine physician at Massachusetts General Hospital Weight Center, who was not involved in the research